Iksuda Therapeutics announces first patient successfully dosed in phase 1 trial evaluating IKS03 in advanced B cell non-Hodgkin lymphomas
NEWCASTLE, England--(BUSINESS WIRE)--Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces the completion of dosing of its first patient with IKS03, a CD19-directed ADC, in a phase 1, first-in-human, clinical trial in patients with advanced B cell non-Hodgkin lymphoma.
This first-in-human study (https://clinicaltrials.gov/study/NCT05365659) will evaluate the safety, tolerability, preliminary antineoplastic activity, pharmacokinetics and pharmacodynamics of increasing dose levels of IKS03, and determine the recommended dose for dose-expansion. Efficacy will be further evaluated in disease-specific expansion cohorts. The study is currently enrolling patients across clinical sites in Italy, Spain, Australia, United States and Canada.
Dr Dave Simpson, Chief Executive Officer, Iksuda Therapeutics, said:
'With the first patient successfully completing the safety evaluation period with IKS03, Iksuda demonstrates its continued commitment to drive its differentiated ADCs through clinical proof of concept, further solidifying our position as a clinical-stage ADC-focused company. Although there have been advances in the treatment of non-Hodgkin lymphoma in recent years, there remains a significant unmet patient need, and we hope that IKS03 will be able to build on the potential benefit-risk profile suggested by the data generated in preclinical studies.'
About IKS03
IKS03 is a best-in-class CD19-targeting ADC delivering a tumour-activated prodrug pyrrolobenzodiazepine (PBD) which was licensed from LigaChem Biosciences (formerly LegoChem Biosciences) (https://iksuda.com/2020/05/licensing-agreement-with-legochem-biosciences/). Preclinical testing demonstrates best-in-class efficacy (vs in-clinic and marketed CD19-targeted therapies) in in vivo xenograft models and significantly raised maximum tolerated dose (MTD) in non-human primate disease models, demonstrating its potential to be the leading anti-CD19 therapy in B-cell cancers.
About Iksuda Therapeutics: www.iksuda.com
Iksuda Therapeutics is a clinical stage, UK-based biotechnology company focussed on the development of class leading antibody drug conjugates (ADCs) targeting difficult-to-treat haematological and solid tumours. Iksuda's pipeline of ADCs is centred on a portfolio of prodrug DNA and protein alkylating payloads in combination with stable conjugation chemistries including its proprietary PermaLink ® platform. The Company's design concepts for ADCs are now clinically validated to significantly improve the therapeutic index of this important modality and improve the outcomes for patients living with cancer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Robocaller behind millions of illegal calls in Ohio permanently banned, attorney general announces
A robocaller responsible for billions of illegal calls has been permanently banned in seven states, according to Ohio Attorney General Dave Yost. [DOWNLOAD: Free WHIO-TV News app for alerts as news breaks] Texas-based robocaller John Spiller previously offered telemarketers robocall dialer and Voice Over Internet Protocol (VoIP) services through his companies Rising Eagle Capital Group, JSquared Telecom, and Rising Eagle Capital Group-Cayman. TRENDING STORIES: Man with filet knife arrested after standoff in Mercer County Local spa accused of operating as brothel; 2 arrested Popular music center gets a new name, $60 million gift to transform the venue Yost said this led to massive amounts of robocalls and often targeted numbers on the Do Not Call Registry. Spiller received a court order that barred him from making or facilitating robocalls in 2023. However, he used different names to create new companies that would continue facilitating the same types of illegal robocalls, according to Yost. These violations prompted eight attorneys general, including Yost, to seek a contempt of court order. Yost announced that a federal judge in Texas found Spiller in contempt of court on Thursday. Spiller is permanently prohibited from launching future telecommunications companies or operating in the telecom industry and must pay $600,000 in fees for violating the 2023 court order. He also cannot collaborate with the people who helped his operation, use aliases in government filings, or make deceptive statements, according to Yost. 'This scammer's line is dead — and it's not coming back,' Yost said. Ohio Attorney General Dave Yost was joined in this effort by the attorneys general of Arkansas, Indiana, Michigan, Missouri, North Carolina, North Dakota and Texas. 'The judge's latest ruling sends a strong message that bad actors cannot evade court orders by simply operating under different business names,' Yost said. [SIGN UP: WHIO-TV Daily Headlines Newsletter]
Yahoo
16 minutes ago
- Yahoo
Trade Secretary to meet US counterpart in bid to secure steel tariff exemption
The Trade Secretary will meet his US counterpart next week as the UK seeks to set a timeline for its exemption from US President Donald Trump's steel tariffs. The meeting will come after Mr Trump said he was doubling tariffs on imports of steel from 25% to 50%. The UK struck a deal with Washington for import taxes on its steel to be removed weeks ago, but its implementation has not been finalised. Trade officials and negotiators are planning to speak to the US as soon as they can to understand the implications of Mr Trump's latest steel tariffs. They want to secure a timeline for the UK-US deal to be implemented as quickly as possible in the coming weeks. Jonathan Reynolds will meet US trade representative Jamieson Greer to discuss timings for the deal to be in place when both attend the OECD (Organisation for Economic Co-operation and Development) meeting in Paris next week. Earlier this week, a federal court blocked many of the sweeping Trump tariffs imposed on imports from countries around the world, but left some in place, including those on foreign steel and aluminium. On Thursday, a federal appeals court said it was allowing Mr Trump to continue collecting import taxes for now. On Friday, Mr Trump announced he would double the tariff rate on steel to 50%, starting on June 4. A Government spokesperson said: 'The UK was the first country to secure a trade deal with the US earlier this month and we remain committed to protecting British business and jobs across key sectors, including steel. 'We are engaging with the US on the implications of the latest tariff announcement and to provide clarity for industry.' The agreement, known as the economic prosperity deal, is expected to be presented to Parliament before it comes into force.
Chicago Tribune
an hour ago
- Chicago Tribune
Iran has amassed even more near weapons-grade uranium, UN watchdog says
VIENNA — Iran has further increased its stockpile of uranium enriched to near weapons-grade levels, a confidential report by the U.N. nuclear watchdog said Saturday. In a separate report, the agency called on Tehran to urgently change course and comply with its years-long probe. The report comes at a sensitive time, as the administration of U.S. President Donald Trump seeks to reach a deal with Tehran to limit its nuclear program. The two sides have held several rounds of talks, so far without agreement. The report by the Vienna-based International Atomic Energy Agency — which was seen by The Associated Press — says that as of May 17, Iran has amassed 408.6 kilograms (900.8 pounds) of uranium enriched up to 60%. That's an increase of 133.8 kilograms (294.9 pounds) — or almost 50% — since the IAEA's last report in February. The 60% enriched material is a short, technical step away from weapons-grade levels of 90%. A report in February put this stockpile level at 274.8 kilograms (605.8 pounds). There was no immediate comment from Tehran on the new IAEA report. The IAEA report raised a stern warning, saying that Iran is now 'the only non-nuclear-weapon state to produce such material' — something the agency said was of 'serious concern.' Approximately 42 kilograms of 60% enriched uranium is theoretically enough to produce one atomic bomb, if enriched further to 90%, according to the watchdog. The IAEA report, a quarterly, also estimated that as of May 17, Iran's overall stockpile of enriched uranium — which includes uranium enriched to lower levels — stood at 9,247.6 kilograms (20,387.4 pounds). That's an increase of 953.2 kilograms (2,101.4 pounds) since February's report. Iran has maintained its nuclear program is for peaceful purposes only, but the IAEA chief, Rafael Mariano Grossi, has warned that Tehran has enough uranium enriched to near-weapons-grade levels to make 'several' nuclear bombs if it chose to do so. Iranian officials have increasingly suggested that Tehran could pursue an atomic bomb. U.S. intelligence agencies assess that Iran has yet to begin a weapons program, but has 'undertaken activities that better position it to produce a nuclear device, if it chooses to do so.' Israel said Saturday's report was a clear warning sign that 'Iran is totally determined to complete its nuclear weapons program,' according to a statement from Prime Minister Benjamin Netanyahu's office. It said IAEA's report 'strongly reinforces what Israel has been saying for years — the purpose of Iran's nuclear program is not peaceful.' It also added that Iran's level of enrichment 'has no civilian justification whatsoever' and appealed on the international community to 'act now to stop Iran.' It is rare for Netanyahu to make statements on Saturday, the Jewish day of rest, underlying the urgency with which he sees the matter. Grossi said Saturday that he 'reiterates his urgent call upon Iran to cooperate fully and effectively' with the IAEA's years long investigation into uranium traces discovered at several sites in Iran. The IAEA also circulated to member states on Saturday a second, 22-page confidential report, also seen by the AP, that Grossi was asked to produce following a resolution passed by the 35-member IAEA Board of Governors last November. In this so-called 'comprehensive report,' the IAEA said that Iran's cooperation with the agency has 'been less than satisfactory' when it comes to uranium traces discovered by IAEA inspectors at several locations in Iran that Tehran has failed to declare as nuclear sites. Western officials suspect that the uranium traces discovered by the IAEA could provide evidence that Iran had a secret military nuclear program until 2003. One of the sites became known publicly in 2018 after Netanyahu revealed it at the United Nations and called it a clandestine nuclear warehouse hidden at a rug-cleaning plant. Iran denied this but in 2019 IAEA inspectors detected the presence of manmade uranium particles there. After initially blocking IAEA access, inspectors were able to collect samples in 2020 from two other locations where they also detected the presence of manmade uranium particles. The three locations became known as Turquzabad, Varamin, and Marivan. A fourth undeclared location named as Lavisan-Shian is also part of the IAEA probe but IAEA inspectors never visited the site because it was razed and demolished by Iran after 2003. In Saturday's comprehensive report, the IAEA says that the 'lack of answers and clarifications provided by Iran' to questions the watchdog had regarding Lavisan-Shian, Varamin and Marivan 'has led the agency to conclude that these three locations, and other possible related locations, were part of an undeclared structured nuclear program carried out by Iran until the early 2000s and that some activities used undeclared nuclear material.' Saturday's comprehensive report could be a basis for possible further steps by European nations, leading to a potential escalation in tensions between Iran and the West. European countries could move to trigger snap-back sanctions against Iran that were lifted under the original 2015 nuclear deal ahead of October, when the deal formally expires. On Thursday, senior Iranian officials dismissed speculation about an imminent nuclear deal with the United States, emphasizing that any agreement must fully lift sanctions and allow the country's nuclear program to continue. The comments came a day after Trump said he has told Netanyahu to hold off on striking Iran to give the U.S. administration more time to push for a new deal with Tehran. Trump said on Friday that he still thinks a deal could be completed in the 'not too distant future.' 'They don't want to be blown up. They would rather make a deal,' Trump said of Iran. He added, 'That would be a great thing that we could have a deal without bombs being dropped all over the Middle East.'
